Report Detail
Global Adrenocortical Carcinoma Drugs Market Size, Status and Forecast 2019-2025
- RnM3664871 |
- 13 August, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Pharma & Healthcare
The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit enhanced diagnostic accuracy in the detection of adrenal lesions.
For instance, unenhanced computed tomography adrenal densitometry is used to differentiate adrenal adenomas from malignant lesions based on the presence of intracellular lipids. A combination of positron emission tomography/computed tomography is also gaining popularity among end-users for the identification of malignant and benign lesions. Similarly, multiphase computed tomography technique is being used to calculate absolute and relative percentage washout, and thereby, differentiate between benign and malignant lesions.
In 2018, the global Adrenocortical Carcinoma Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Bristol-Myers Squibb Co.
Eli Lilly and Co.
Laboratoire HRA Pharma SAS
Progenics Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
...
Market segment by Type, the product can be split into
Chemotherapy
Targeted therapy
Market segment by Application, split into
Hospital
Research institute
Clinic
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players.
To present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Adrenocortical Carcinoma Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Chemotherapy
- 1.4.3 Targeted therapy
- 1.5 Market by Application
- 1.5.1 Global Adrenocortical Carcinoma Drugs Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Research institute
- 1.5.4 Clinic
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Adrenocortical Carcinoma Drugs Market Size
- 2.2 Adrenocortical Carcinoma Drugs Growth Trends by Regions
- 2.2.1 Adrenocortical Carcinoma Drugs Market Size by Regions (2019-2025)
- 2.2.2 Adrenocortical Carcinoma Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Adrenocortical Carcinoma Drugs Market Size by by Players
- 3.1.1 Global Adrenocortical Carcinoma Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Adrenocortical Carcinoma Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Adrenocortical Carcinoma Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Adrenocortical Carcinoma Drugs Key Players Head office and Area Served
- 3.3 Key Players Adrenocortical Carcinoma Drugs Product/Solution/Service
- 3.4 Date of Enter into Adrenocortical Carcinoma Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Adrenocortical Carcinoma Drugs Market Size by Type (2014-2019)
- 4.2 Global Adrenocortical Carcinoma Drugs Market Size by Application (2014-2019)
5 North America
- 5.1 North America Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 5.2 Adrenocortical Carcinoma Drugs Key Players in North America
- 5.3 North America Adrenocortical Carcinoma Drugs Market Size by Type
- 5.4 North America Adrenocortical Carcinoma Drugs Market Size by Application
6 Europe
- 6.1 Europe Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 6.2 Adrenocortical Carcinoma Drugs Key Players in Europe
- 6.3 Europe Adrenocortical Carcinoma Drugs Market Size by Type
- 6.4 Europe Adrenocortical Carcinoma Drugs Market Size by Application
7 China
- 7.1 China Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 7.2 Adrenocortical Carcinoma Drugs Key Players in China
- 7.3 China Adrenocortical Carcinoma Drugs Market Size by Type
- 7.4 China Adrenocortical Carcinoma Drugs Market Size by Application
8 Japan
- 8.1 Japan Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 8.2 Adrenocortical Carcinoma Drugs Key Players in Japan
- 8.3 Japan Adrenocortical Carcinoma Drugs Market Size by Type
- 8.4 Japan Adrenocortical Carcinoma Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 9.2 Adrenocortical Carcinoma Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type
- 9.4 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application
10 India
- 10.1 India Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 10.2 Adrenocortical Carcinoma Drugs Key Players in India
- 10.3 India Adrenocortical Carcinoma Drugs Market Size by Type
- 10.4 India Adrenocortical Carcinoma Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Adrenocortical Carcinoma Drugs Market Size (2014-2019)
- 11.2 Adrenocortical Carcinoma Drugs Key Players in Central & South America
- 11.3 Central & South America Adrenocortical Carcinoma Drugs Market Size by Type
- 11.4 Central & South America Adrenocortical Carcinoma Drugs Market Size by Application
12 International Players Profiles
- 12.1 Bristol-Myers Squibb Co.
- 12.1.1 Bristol-Myers Squibb Co. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Adrenocortical Carcinoma Drugs Introduction
- 12.1.4 Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019))
- 12.1.5 Bristol-Myers Squibb Co. Recent Development
- 12.2 Eli Lilly and Co.
- 12.2.1 Eli Lilly and Co. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Adrenocortical Carcinoma Drugs Introduction
- 12.2.4 Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
- 12.2.5 Eli Lilly and Co. Recent Development
- 12.3 Laboratoire HRA Pharma SAS
- 12.3.1 Laboratoire HRA Pharma SAS Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Adrenocortical Carcinoma Drugs Introduction
- 12.3.4 Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
- 12.3.5 Laboratoire HRA Pharma SAS Recent Development
- 12.4 Progenics Pharmaceuticals Inc.
- 12.4.1 Progenics Pharmaceuticals Inc. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Adrenocortical Carcinoma Drugs Introduction
- 12.4.4 Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
- 12.4.5 Progenics Pharmaceuticals Inc. Recent Development
- 12.5 Teva Pharmaceutical Industries Ltd.
- 12.5.1 Teva Pharmaceutical Industries Ltd. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Adrenocortical Carcinoma Drugs Introduction
- 12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
- 12.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on AdrenocorticalCarcinomaDrugs. Industry analysis & Market Report on AdrenocorticalCarcinomaDrugs is a syndicated market report, published as Global Adrenocortical Carcinoma Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of AdrenocorticalCarcinomaDrugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
